Nature research paper: Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.SARS-CoV-2 Delta and Omicron are globally relevant variants of concern .
Noah Brazer, Prachi Saldhi, Alicia Sotomayor-Gonzalez, Venice Servellita, Amelia Gliwa, Jenny Nguyen & Charles Y. ChiuMauricio Montano & Warner C. Greene Ines Silva, Bilal Milbes, Noah Kojima, Victoria Hess, Maria Shacreaw, Lauren Lopez, Matthew Brobeck, Fred Turner & Lee SpraggonAshley F. George & Nadia R. Roan
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 - NatureNature - Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
Les mer »
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2 - NatureNature - Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
Les mer »
FDA authorizes Pfizer Covid booster for children 5 to 11 years oldA study in February found that two doses of the vaccine offered little protection against the omicron variant.
Les mer »
South Africa in new surge of COVID from versions of omicronSouth Africa’s new cases have gone from an average of 300 per day in early April to about 8,000 per day this week. The new surge is from two variations of omicron, BA.4 and BA.5, which appear to be very much like the original strain of omicron.
Les mer »
North Korean leader Kim slams officials' 'immaturity' in response to COVID outbreakThe country has not started mass vaccinations and has limited testing capabilities.
Les mer »